Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Clarus Therapeutics Holdings Inc
Inventory
Clarus Therapeutics Holdings Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
|
Inventory
$14.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Johnson & Johnson
NYSE:JNJ
|
Inventory
$11.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Inventory
$3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
6%
|
|
Pfizer Inc
NYSE:PFE
|
Inventory
$10.9B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Merck & Co Inc
NYSE:MRK
|
Inventory
$6.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Inventory
$6.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
See Also
What is Clarus Therapeutics Holdings Inc's Inventory?
Inventory
14.2m
USD
Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Inventory amounts to 14.2m USD.
What is Clarus Therapeutics Holdings Inc's Inventory growth rate?
Inventory CAGR 1Y
143%
Over the last year, the Inventory growth was 143%.